세계의 경동맥 접근 장치 시장 : 기회, 성장 촉진요인, 산업 동향 분석 및 예측(2025-2034년)

The Global Transradial Access Devices Market was valued at USD 2.4 billion in 2024 and is estimated to grow at a CAGR of 7.7% to reach USD 5.1 billion by 2034, driven by the increasing prevalence of cardiovascular diseases (CVDs) and the rising preference for minimally invasive interventional procedures. Transradial access is gaining traction due to its ability to offer faster patient recovery, reduced risk of bleeding, and shorter hospital stays compared to traditional methods. The shift toward radial artery access has reshaped clinical practice, as healthcare providers prioritize safety, comfort, and efficiency. The trend toward using radial-first approaches in catheterization laboratories has been further fueled by its demonstrated clinical reliability and operational benefits.

This increasing reliance on radial techniques drives strong demand for transradial access devices worldwide, including components such as sheaths, guidewires, hemostasis bands, and catheters. The clinical advantages of the radial approach-such as lower bleeding risk, faster patient mobilization, and shorter hospital stays-continue to shape procedural protocols in interventional cardiology. As healthcare providers aim to optimize efficiency and patient satisfaction, adopting radial-first strategies is expanding not only in developed markets but also gaining momentum in emerging economies with improving cardiovascular infrastructure.

Catheters currently lead the product segment with a commanding market share of 49.4% in 2024. Their effectiveness in navigating complex vascular networks and facilitating accurate device delivery makes them vital in diagnostic and therapeutic cardiac procedures. Innovation in catheter designs, such as improved torque response, enhanced flexibility, and hydrophilic coatings, has significantly boosted procedural success rates and overall patient outcomes. Furthermore, next-generation catheters designed specifically for transradial interventions contribute to reduced access site complications and increased procedural efficiency.

Additionally, the drug administration segment holds a 36.8% market share in 2024 and is forecasted to reach USD 1.8 billion by 2034. The ability of these devices to deliver targeted medications directly to affected areas not only enhances therapeutic results but also shortens recovery times. This capability is important in acute cardiovascular events, where rapid drug delivery can be life-saving. Transradial access is now being increasingly explored for broader applications, thanks to its precision and minimally invasive nature. Its growing role in delivering pharmacological agents for cardiac and non-cardiac conditions reflects the adaptability and expanding scope of transradial solutions.

U.S. Transradial Access Devices Market generated USD 881.8 million in 2024, driven by the number of cardiovascular interventions, supportive reimbursement policies, and operator preference for radial access, which is accelerating adoption. Increased awareness of the benefits of transradial procedures is leading to greater integration across healthcare systems. Hospitals are rapidly transitioning to outpatient-based PCI models, taking advantage of the reduced recovery time and procedural simplicity of radial access. Regulatory support, clinical training programs, and investment in advanced cath lab infrastructure further reinforce the widespread use of these devices. This progressive environment ensures that transradial access remains at the forefront of interventional cardiology innovation in the region.

Key players operating in this space include Boston Scientific, Alvimedica, Becton Dickinson and Company, Terumo, Medtronic, Teleflex, Palex Medical, ICU Medical, InnoMedica, Cardinal Health, Merit Medical System, Edward Lifesciences, NIPRO Medical, Ameco Medical Industries, AngioDynamics, and Oscor. To secure a competitive edge, leading companies are focusing on product innovation and technological upgrades. They invest in advanced materials, ergonomic designs, and improved functionality to boost clinician usability and patient comfort. Many firms expand their geographic footprint through strategic partnerships, mergers, and acquisitions. Collaborations with hospitals and healthcare networks help in early adoption and market penetration.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of cardiovascular disease in developed and developing economies
    • 3.2.1.2 Growth in elderly age group
    • 3.2.1.3 Rising preference for interventional procedures using radial artery access
    • 3.2.1.4 Growing use of radial access devices in pediatric patients
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Stringent regulatory framework
    • 3.2.2.2 High cost and maintenance of vascular access devices
    • 3.2.2.3 Dearth of cardiothoracic surgeons in developing nations
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Trump administration tariffs
  • 3.6.1 Impact on trade
    • 3.6.1.1 Trade volume disruptions
    • 3.6.1.2 Retaliatory measures
  • 3.6.2 Impact on the Industry
    • 3.6.2.1 Supply-side impact (raw materials)
      • 3.6.2.1.1 Price volatility in key materials
      • 3.6.2.1.2 Supply chain restructuring
      • 3.6.2.1.3 Production cost implications
    • 3.6.2.2 Demand-side impact (selling price)
      • 3.6.2.2.1 Price transmission to end markets
      • 3.6.2.2.2 Market share dynamics
      • 3.6.2.2.3 Consumer response patterns
  • 3.6.3 Key companies impacted
  • 3.6.4 Strategic industry responses
    • 3.6.4.1 Supply chain reconfiguration
    • 3.6.4.2 Pricing and product strategies
    • 3.6.4.3 Policy engagement
  • 3.6.5 Outlook and future considerationsTrump administration tariffs
• 3.7 Future market trends
• 3.8 Gap analysis
• 3.9 Patent analysis
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Competitive analysis of major market players
• 4.3 Competitive positioning matrix
• 4.4 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Catheters
• 5.3 Guidewires
• 5.4 Sheath and sheath introducers
• 5.5 Accessories

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Drug administration
• 6.3 Fluid and nutrition administration
• 6.4 Blood transfusion
• 6.5 Diagnostics and testing
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals and clinics
• 7.3 Ambulatory surgical centers
• 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 South Korea
  • 8.4.5 Australia
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Alvimedica
• 9.2 Ameco Medical Industries
• 9.3 AngioDynamics
• 9.4 Becton Dickinson and Company
• 9.5 Boston Scientific
• 9.6 Cardinal Health
• 9.7 Edward Lifesciences
• 9.8 ICU Medical
• 9.9 InnoMedica
• 9.10 Medtronic
• 9.11 Merit Medical System
• 9.12 NIPRO Medical
• 9.13 Oscor
• 9.14 Palex Medical
• 9.15 Teleflex
• 9.16 Terumo